OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis

Volume: 23, Issue: 5, Pages: 686 - 697
Published: May 1, 2015
Abstract
The objective of this work was to describe requirements for inclusion of soluble biomarkers in osteoarthritis (OA) clinical trials and progress toward OA-related biomarker qualification. The Guidelines for Biomarkers Working Group, representing experts in the field of OA biomarker research from both academia and industry, convened to discuss issues related to soluble biomarkers and to make recommendations for their use in OA clinical trials...
Paper Details
Title
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis
Published Date
May 1, 2015
Volume
23
Issue
5
Pages
686 - 697
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.